T0	Participants 13 33	atrial fibrillation.
T1	Participants 177 208	nonvalvular atrial fibrillation
T2	Participants 233 280	patients using 2 different elicitation methods.
T3	Participants 504 644	practices of 2 university-affiliated family medicine centers (8 physicians each), 14 community-based family physicians, and 2 cardiologists.
T4	Participants 654 787	Sixty-four patients with nonvalvular atrial fibrillation who were initiated with warfarin therapy at least 3 months before the study.
T5	Participants 2234 2280	patients with nonvalvular atrial fibrillation.